Skip to content

Phoenix Life Sciences International Limited.: 10-Q filed 2015-03-09

What Phoenix Life Sciences International Limited. reported in its quarterly report filed 2015-03-09 (fiscal Q3 2015): 19 published measures, 52 facts as tagged in accession 0001014897-15-000059.

This filing

Form
10-Q (quarterly report)
Filed
2015-03-09
Fiscal period
fiscal Q3 2015
Accession
0001014897-15-000059 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Phoenix Life Sciences International Limited. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-11-3013,062,593USD
At 2014-02-286,104USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-11-30324,487USD
At 2014-02-2810,436USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-11-3012,738,106USD
At 2014-02-28-4,332USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-09-01 to 2014-11-30-1,197,896USD91
2014-03-01 to 2014-11-30-2,262,566USD275
2013-09-01 to 2013-11-30-78,908USD91
2013-03-01 to 2013-11-30-117,433USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-03-01 to 2014-11-30-993,753USD275
2013-03-01 to 2013-11-30-35,456USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-09-01 to 2014-11-3017,936USD91
2014-03-01 to 2014-11-3020,716USD275
2013-09-01 to 2013-11-300USD91
2013-03-01 to 2013-11-300USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-11-30-2,929,817USD
At 2014-02-28-667,252USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-11-30539,593USD
At 2014-02-286,104USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-09-01 to 2014-11-30-4,466USD91
2014-03-01 to 2014-11-30-7,756USD275
2013-09-01 to 2013-11-300USD91
2013-03-01 to 2013-11-300USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-11-30157,238USD
At 2014-02-2810,016USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-09-01 to 2014-11-301,200,876USD91
2014-03-01 to 2014-11-301,709,795USD275
2013-09-01 to 2013-11-300USD91
2013-03-01 to 2013-11-300USD275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-11-3013,611USD
At 2014-02-280USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-09-01 to 2014-11-308,792USD91
2014-03-01 to 2014-11-3010,022USD275
2013-09-01 to 2013-11-300USD91
2013-03-01 to 2013-11-300USD275

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-09-01 to 2014-11-309,144USD91
2014-03-01 to 2014-11-3010,694USD275
2013-09-01 to 2013-11-300USD91
2013-03-01 to 2013-11-300USD275

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-11-3014,605,788USD
At 2014-02-28599,920USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-09-01 to 2014-11-30109,419USD91
2014-03-01 to 2014-11-30168,450USD275
2013-09-01 to 2013-11-300USD91
2013-03-01 to 2013-11-300USD275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-03-01 to 2014-11-30975,925USD275
2013-03-01 to 2013-11-300USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-03-01 to 2014-11-30-3,180USD275
2013-03-01 to 2013-11-300USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-03-01 to 2014-11-30-13,611USD275
2013-03-01 to 2013-11-300USD275

Inspect the source

Entity
Phoenix Life Sciences International Limited. / CIK 0001493212
Captured
SEC response SHA-256
e9e4eff3c476f5eb033bab91a133e7dfeaf63cfa51c8097afeedbc2cb284bfb3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001493212.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))